Showing results (31-40 of 93) with videos related to

Sort By:
Pageof 10
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|May 7, 2016
Successful immune tolerance induction using turoctocog alfa in an adult haemophilia A patientClemens Feistritzer, Sophie Maria Wildner, Philipp Würtinger, et al.
Wiener Klinische Wochenschrift|August 16, 2019
Recommendations for ibrutinib treatment in patients with atrial fibrillation and/or elevated cardiovascular riskMarkus C Stühlinger, Ansgar Weltermann, Philipp Staber, et al.
Behavioural Processes|June 20, 2014
Touchscreen performance and knowledge transfer in the red-footed tortoise (Chelonoidis carbonaria)Julia Mueller-Paul, Anna Wilkinson, Ulrike Aust, et al.
Annals of Hematology|October 11, 2008
Hodgkin lymphoma in Tyrol-a population-based studyDominic Fong, Michael Steurer, Richard Greil, et al.
Blood|August 29, 2009
GRP-78 secreted by tumor cells blocks the antiangiogenic activity of bortezomibJohann Kern, Gerold Untergasser, Christoph Zenzmaier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 11, 2003
Increase of regulatory T cells in the peripheral blood of cancer patientsAnna Maria Wolf, Dominik Wolf, Michael Steurer, et al.
Haematologica|September 8, 2006
The effect of IgVH mutational status on the induction of apoptosis by rituximab in patients with heavily pretreated B-cell chronic lymphocytic leukemia: evidence from a clinical phase I/II trialInge Tinhofer, Michael Steurer, Gabriele Leitinger, et al.
Human Pathology|April 17, 2002
Hepatosplenic gammadelta-T-cell lymphoma with leukemic course after renal transplantationMichael Steurer, Reinhard Stauder, Kurt Grünewald, et al.
Clinical Therapeutics|March 24, 2009
Pharmacokinetics, bioequivalence, tolerability, and effects on platelet counts of two formulations of anagrelide in healthy volunteers and patients with thrombocythemia associated with chronic myeloproliferationPetro E Petrides, Heinz Gisslinger, Michael Steurer, et al.
Cancer|October 12, 2004
Anagrelide for thrombocytosis in myeloproliferative disorders: a prospective study to assess efficacy and adverse event profileMichael Steurer, Guenther Gastl, Wieslaw-Wiktor Jedrzejczak, et al.
Pageof 10